GSK ups guidance and unveils major restructure

25th July 2018 Uncategorised 0

GlaxoSmithKline has upped its expectations for the year after a strong performance by its vaccines division in the second quarter and the delay of a potential generic version of Advair in the US.

More: GSK ups guidance and unveils major restructure
Source: News